Zi-Yue Wan

560 total citations
17 papers, 457 citations indexed

About

Zi-Yue Wan is a scholar working on Nephrology, Molecular Biology and Pharmacology. According to data from OpenAlex, Zi-Yue Wan has authored 17 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Zi-Yue Wan's work include Renal Diseases and Glomerulopathies (4 papers), Inflammasome and immune disorders (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Zi-Yue Wan is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Inflammasome and immune disorders (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Zi-Yue Wan collaborates with scholars based in China, Japan and Malaysia. Zi-Yue Wan's co-authors include Yue Tu, Yi‐Gang Wan, Yinglu Liu, Bu-Hui Liu, Qi‐Jun Fang, Renmao Tang, Wei Wu, Haitao Tang, Meizi Wang and Liang Yue and has published in prestigious journals such as Frontiers in Pharmacology, Phytomedicine and Aging.

In The Last Decade

Zi-Yue Wan

15 papers receiving 453 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zi-Yue Wan 248 153 56 47 42 17 457
Bu-Hui Liu 198 0.8× 108 0.7× 50 0.9× 40 0.9× 41 1.0× 21 378
Yilan Shen 212 0.9× 99 0.6× 60 1.1× 51 1.1× 42 1.0× 20 453
Yanru Huang 183 0.7× 79 0.5× 42 0.8× 45 1.0× 36 0.9× 29 434
Enchao Zhou 204 0.8× 105 0.7× 40 0.7× 41 0.9× 46 1.1× 25 487
Xisheng Xie 251 1.0× 150 1.0× 65 1.2× 29 0.6× 38 0.9× 40 549
Yuebo Huang 315 1.3× 123 0.8× 60 1.1× 87 1.9× 44 1.0× 14 587
Hengjiang Guo 247 1.0× 196 1.3× 135 2.4× 62 1.3× 76 1.8× 14 647
Montserrat B. Duran-Salgado 107 0.4× 109 0.7× 47 0.8× 44 0.9× 42 1.0× 6 349
Shuang Chu 148 0.6× 83 0.5× 83 1.5× 52 1.1× 94 2.2× 12 434

Countries citing papers authored by Zi-Yue Wan

Since Specialization
Citations

This map shows the geographic impact of Zi-Yue Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Yue Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Yue Wan more than expected).

Fields of papers citing papers by Zi-Yue Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Yue Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Yue Wan. The network helps show where Zi-Yue Wan may publish in the future.

Co-authorship network of co-authors of Zi-Yue Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Yue Wan. A scholar is included among the top collaborators of Zi-Yue Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Yue Wan. Zi-Yue Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
Wang, Meizi, Jie Wang, Dongwei Cao, et al.. (2022). Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis. Frontiers in Pharmacology. 13. 790937–790937. 47 indexed citations
5.
Liu, Bu-Hui, Yinglu Liu, Haiming Yang, et al.. (2021). Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis. Frontiers in Pharmacology. 11. 586725–586725. 14 indexed citations
6.
7.
Wang, Wenwen, Yinglu Liu, Meizi Wang, et al.. (2021). Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy. Frontiers in Pharmacology. 12. 662706–662706. 28 indexed citations
8.
Wang, Meizi, Lijun Yue, Yi‐Gang Wan, et al.. (2021). [Effects and mechanisms of Supplemented Gegen Qinlian Decoction Formula against podocyte pyroptosis and insulin resistance in model rats with diabetic kidney disease].. China Journal of Chinese Materia Medica. 46(17). 4471–4479. 2 indexed citations
9.
10.
Wu, Wei, Bu-Hui Liu, Yi‐Gang Wan, et al.. (2019). [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].. PubMed. 44(24). 5457–5464. 10 indexed citations
11.
Liu, Yinglu, Ge Shi, Wenwen Wang, et al.. (2019). Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition.. PubMed. 11(4). 1980–1996. 17 indexed citations
12.
Tu, Yue, Yi‐Gang Wan, Bu-Hui Liu, et al.. (2019). [Molecular mechanisms of non-coding RNA regulating autophagy and interventional effects of Chinese herbal medicine].. PubMed. 44(21). 4545–4551. 2 indexed citations
13.
Wu, Wei, Yinglu Liu, Yue Tu, et al.. (2018). Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy. Frontiers in Pharmacology. 9. 443–443. 60 indexed citations
14.
15.
16.
Liu, Bu-Hui, Yue Tu, Weiming He, et al.. (2018). Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy. Aging. 10(12). 4197–4212. 61 indexed citations
17.
Liu, Bu-Hui, Yi-Huang Gu, Yue Tu, et al.. (2017). [Molecular regulative mechanisms of aging and interventional effects of Chinese herbal medicine].. PubMed. 42(16). 3065–3071. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bu-Hui Liu Breakdown of academic impact, for papers by Yilan Shen Breakdown of academic impact, for papers by Yanru Huang Breakdown of academic impact, for papers by Enchao Zhou Breakdown of academic impact, for papers by Xisheng Xie Breakdown of academic impact, for papers by Yuebo Huang Breakdown of academic impact, for papers by Hengjiang Guo Breakdown of academic impact, for papers by Montserrat B. Duran-Salgado Breakdown of academic impact, for papers by Shuang Chu
Rankless by CCL
2026